SAN CARLOS, Calif.–(BUSINESS WIRE)– #AI–Today, Acrobat Genomics (“Acrobat”), a biotechnology company that teaches AI to design proteins using functional data measured directly in human cells, announced the successful completion of Phase I and commencement of expanded research within the Defense Advanced Research Projects Agency (DARPA) Rapid Inhibitor Discovery and Development pipeLine (RIDDL) program as a prime contractor. RIDDL seeks transformative approaches to rapidly discover, design, and dev